Thanh bên bài viết
Ngày xuất bản:
26/06/2024
Số lượt xem tóm tắt: 37
Số lượt xem pdf: 22
Số lượt xem pdf: 22
Số xuất bản
Chuyên mục
KHOA HỌC Y DƯỢC
Trích dẫn bài báo
Nguyễn, T. K., Phạm, T. K. H., Nguyễn, T. H. V., Lê, B. N., & Nguyễn, N. L. (2024). Molecular Docking Approach to Identify Flavonoids as Potential Phosphodiesterase 5 Inhibitors for Erectile Dysfunction Treatment. Tạp chí Khoa học Đại học Đông Á, 3(2). https://doi.org/10.59907/daujs.3.2.2024.283
Molecular Docking Approach to Identify Flavonoids as Potential Phosphodiesterase 5 Inhibitors for Erectile Dysfunction Treatment
Nội dung chính của bài viết
Tóm tắt
An erection that is not strong enough for sexual activity might be caused by erectile dysfunction. Periodically experiencing difficulties achieving an erection is not always a reason for alarm. On the other hand, if erectile dysfunction persists, it may lead to stress, undermine confidence, and exacerbate interpersonal issues. In addition to being a risk factor for heart disease, difficulties achieving or maintaining an erection may also indicate an underlying medical issue that needs to be treated. Many studies have also steadily examined flavonoids' capacity to inhibit the phosphodiesterase 5 enzyme in several recent studies. This is an enzyme expressed in erectile tissue that is the most important substance that degrades cGMP in the body's smooth muscle cells. This study identified two prominent flavonoids that had inhibitory effects on the phosphodiesterase 5 enzyme: Amenoflavone and Umbralisib. Our research suggests new molecular pathways by which these substances might influence biological processes. One compound that shows promise for treating erectile dysfunction and is safe for healthy cells is Amentoflavone.
Chi tiết bài viết
Từ khóa
Erectile dysfunction, Phosphodiesterase 5, virtual screening, molecular docking
Tài liệu tham khảo
Adefegha, S. A., Oyeleye, S. I., Dada, F. A., Olasehinde, T. A., & Oboh, G. (2018). Modulatory effect of quercetin and its glycosylated form on key enzymes and antioxidant status in rats penile tissue of paroxetine-induced erectile dysfunction. Biomedicine & Pharmacotherapy, 107, 1473-1479. https://doi.org/https://doi.org/10.1016/j.biopha.2018.08.128
Albersen, M., Fandel, T. M., Lin, G., Wang, G., Banie, L., Lin, C.-S., & Lue, T. F. (2010). Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. The journal of sexual medicine, 7(10), 3331-3340. https://doi.org/https://doi.org/10.1111/j.1743-6109.2010.01875.x
Aytaç, Mckinlay, & Krane. (1999). The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU international, 84(1), 50-56. https://doi.org/https://doi.org/10.1046/j.1464-410x.1999.00142.x
Beaudreau, S. A., Van Moorleghem, K., Dodd, S. M., Liou-Johnson, V., Suresh, M., & Gould, C. E. (2021). Satisfaction with a vacuum constriction device for erectile dysfunction among middle-aged and older veterans. Clinical Gerontologist, 44(3), 307-315. https://doi.org/https://doi.org/10.1080/07317115.2020.1823922
Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the Rule of 5 and drugability. Advanced drug delivery reviews, 101, 89-98. https://doi.org/https://doi.org/10.1016/j.addr.2016.05.007
Bilal, A., & Abbasi, N. U. H. (2020). Cognitive behavioral sex therapy: An emerging treatment option for nonorganic erectile dysfunction in young men: A feasibility pilot study. Sexual medicine, 8(3), 396-407. https://doi.org/https://doi.org/10.1016/j.esxm.2020.05.005
Boulton, A., Selam, J.-L., Sweeney, M., & Ziegler, D. (2001). Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia, 44, 1296-1301. https://doi.org/https://doi.org/10.1007/s001250100656
Casiraghi, F., Remuzzi, G., Abbate, M., & Perico, N. (2013). Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem cell reviews and reports, 9(1), 65-79. https://doi.org/https://doi.org/10.1007/s12015-011-9345-4
Ciocanel, O., Power, K., & Eriksen, A. (2019). Interventions to treat erectile dysfunction and premature ejaculation: an overview of systematic reviews. Sexual medicine, 7(3), 251-269. https://doi.org/https://doi.org/10.1016/j.esxm.2019.06.001
Cosconati, S., Forli, S., Perryman, A. L., Harris, R., Goodsell, D. S., & Olson, A. J. (2010). Virtual screening with AutoDock: theory and practice. Expert opinion on drug discovery, 5(6), 597-607. https://doi.org/https://doi.org/10.1517/17460441.2010.484460
Christensen, B. S., Grønbæk, M., Osler, M., Pedersen, B. V., Graugaard, C., & Frisch, M. (2011). Associations between physical and mental health problems and sexual dysfunctions in sexually active Danes. The journal of sexual medicine, 8(7), 1890-1902. https://doi.org/https://doi.org/10.1111/j.1743-6109.2010.02145.x
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1), 42717. https://doi.org/https://doi.org/10.1038/srep42717
Di, L. (2014). The role of drug metabolizing enzymes in clearance. Expert opinion on drug metabolism & toxicology, 10(3), 379-393. https://doi.org/https://doi.org/10.1517/17425255.2014.876006
Elena, B. W., Zachary, M., Haritha, P., Graham, B. A., & Wayne, H. J. (2023). Current status of intracavernosal injection therapy in erectile dysfunction. Expert Opinion on Pharmacotherapy, 24(8), 925-933. https://doi.org/https://doi.org/10.1080/14656566.2023.2204189
Ferguson III, J. E., & Carson III, C. C. (2013). Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons. Arab Journal of Urology, 11(3), 222-229. https://doi.org/https://doi.org/10.1016/j.aju.2013.07.009
Francis, S. H., & Corbin, J. D. (2005). Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction. Expert opinion on drug metabolism & toxicology, 1(2), 283-293. https://doi.org/https://doi.org/10.1517/17425255.1.2.283
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006). Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nature reviews Drug discovery, 5(8), 689-702. https://doi.org/https://doi.org/10.1038/nrd2030
Gu, S. j., Li, M., Yuan, Y. m., Xin, Z. c., & Guan, R. l. (2021). A novel flavonoid derivative of icariside II improves erectile dysfunction in a rat model of cavernous nerve injury. Andrology, 9(6), 1893-1901. https://doi.org/https://doi.org/10.1111/andr.13065
Giuliano, F., Denys, P., & Joussain, C. (2023). Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data. Toxins, 15(6), 382. https://doi.org/https://doi.org/10.3390/toxins15060382
Hatzimouratidis, K., & Hatzichristou, D. G. (2004). Treatment options for erectile dysfunction in patients failing oral drug therapy. EAU Update Series, 2(2), 75-83. https://doi.org/https://doi.org/10.1016/j.euus.2004.03.001
Hatzimouratidis, K., & Hatzichristou, D. G. (2005). A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs, 65, 1621-1650. https://doi.org/https://doi.org/10.2165/00003495-200565120-00003
Hatzimouratidis, K., Salonia, A., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., McCullough, A., Torres, L. O., & Khera, M. (2016). Pharmacotherapy for erectile dysfunction: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). The journal of sexual medicine, 13(4), 465-488. https://doi.org/https://doi.org/10.1016/j.jsxm.2016.01.016
Hollenberg, P. F. (2002). Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug metabolism reviews, 34(1-2), 17-35. https://doi.org/https://doi.org/10.1081/DMR-120001387
Huang, S. M., Strong, J. M., Zhang, L., Reynolds, K. S., Nallani, S., Temple, R., Abraham, S., Habet, S. A., Baweja, R. K., & Burckart, G. J. (2008). New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. The Journal of clinical pharmacology, 48(6), 662-670. https://doi.org/https://doi.org/10.1177/0091270007312153
Jarow, J. P., Nana-Sinkam, P., Sabbagh, M., & Eskew, A. (1996). Outcome analysis of goal directed therapy for impotence. The Journal of urology, 155(5), 1609-1612. https://doi.org/https://doi.org/10.1016/S0022-5347(01)66142-1
Jones, P., Sandoval Barba, H., Johnson, M. I., Soomro, N., Robson, W., Ferguson, J., & Aning, J. J. (2021). Erectile dysfunction after robotic radical prostatectomy: real-life impact of vacuum erection device clinic. Journal of Clinical Urology, 14(5), 325-331. https://doi.org/https://doi.org/10.1177/205141582094663
Kalsi, J., & Kell, P. (2004). Update on oral treatments for male erectile dysfunction. Journal of the European Academy of Dermatology and Venereology, 18(3), 267-274. https://doi.org/https://doi.org/10.1111/j.1468-3083.2004.00885.x
Karakus, S., & Burnett, A. L. (2020). The medical and surgical treatment of erectile dysfunction: a review and update. Can J Urol, 27(S3), 28-35.
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015). Predicting drug metabolism: experiment and/or computation? Nature reviews Drug discovery, 14(6), 387-404. https://doi.org/https://doi.org/10.1038/nrd4581
Khayyamfar, F., Foroutan, S. K., Farhadi, E., & Ghasemlouei, A. (2021). The impact of vacuum constrictive device on the treatment of erectile dysfunction in spinal cord injured patients. Translational Research in Urology, 3(4), 170-175. https://doi.org/https://doi.org/10.22034/TRU.2021.314753.1087
Langarizadeh, M. A., Salary, A., Tavakoli, M. R., Nejad, B. G., Fadaei, S., Jahani, Z., & Forootanfar, H. (2023). An overview of the history, current strategies, and potential future treatment approaches in erectile dysfunction: a comprehensive review. Sexual Medicine Reviews, qead014. https://doi.org/https://doi.org/10.1093/sxmrev/qead014
Lewis, R. (2004). Definition, classification, and epidemiology of sexual dysfunction. Sexual dysfunction, 3-37.
Lin, G., Banie, L., Ning, H., Bella, A. J., Lin, C. S., & Lue, T. F. (2009). Potential of adipose‐derived stem cells for treatment of erectile dysfunction. The journal of sexual medicine, 6(Supplement_3), 320-327. https://doi.org/https://doi.org/10.1111/j.1743-6109.2008.01190.x
Lin, G., Yang, R., Banie, L., Wang, G., Ning, H., Li, L. C., Lue, T. F., & Lin, C. S. (2010). Effects of transplantation of adipose tissue‐derived stem cells on prostate tumor. The Prostate, 70(10), 1066-1073. https://doi.org/https://doi.org/10.1002/pros.21140
Lue, T. F., Giuliano, F., Montorsi, F., Rosen, R. C., Andersson, K. E., Althof, S., Christ, G., Hatzichristou, D., Hirsch, M., & Kimoto, Y. (2004). Summary of the recommendations on sexual dysfunctions in men. The journal of sexual medicine, 1(1), 6-23. https://doi.org/https://doi.org/10.1111/j.1743-6109.2004.10104.x
Mangner, N., Linke, A., Oberbach, A., Kullnick, Y., Gielen, S., Sandri, M., Hoellriegel, R., Matsumoto, Y., Schuler, G., & Adams, V. (2013). Exercise training prevents TNF-α induced loss of force in the diaphragm of mice. PLoS One, 8(1), e52274. https://doi.org/https://doi.org/10.1371/journal.pone.0052274
McCabe, M. P., Sharlip, I. D., Lewis, R., Atalla, E., Balon, R., Fisher, A. D., Laumann, E., Lee, S. W., & Segraves, R. T. (2016). Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. The journal of sexual medicine, 13(2), 144-152. https://doi.org/https://doi.org/10.1016/j.jsxm.2015.12.034
Mukherjee, A., Su, A., & Rajan, K. (2021). Deep learning model for identifying critical structural motifs in potential endocrine disruptors. Journal of chemical information and modeling, 61(5), 2187-2197. https://doi.org/https://doi.org/10.1021/acs.jcim.0c01409
O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of cheminformatics, 3(1), 1-14. https://doi.org/https://doi.org/10.1186/1758-2946-3-33
Padma-Nathan, H., & Giuliano, F. (2001). Oral drug therapy for erectile dysfunction. Urologic Clinics of North America, 28(2), 321-334. https://doi.org/https://doi.org/10.1016/S0094-0143(05)70141-5
Peng, Z., Yang, L., Dong, Q., Wei, Q., Liu, L., & Yang, B. (2017). Efficacy and safety of tadalafil once-a-day versus tadalafil on-demand in patients with erectile dysfunction: a systematic review and meta-analyses. Urologia Internationalis, 99(3), 343-352. https://doi.org/https://doi.org/10.1159/000477496
Porst, H., Burnett, A., Brock, G., Ghanem, H., Giuliano, F., Glina, S., Hellstrom, W., Martin-Morales, A., Salonia, A., & Sharlip, I. (2013). SOP conservative (medical and mechanical) treatment of erectile dysfunction. The journal of sexual medicine, 10(1), 130-171. https://doi.org/https://doi.org/10.1111/jsm.12023
Prockop, D. (2007). “Stemness” does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clinical Pharmacology & Therapeutics, 82(3), 241-243. https://doi.org/https://doi.org/10.1038/sj.clpt.6100313
Protogerou, V., Chrysikos, D., Karampelias, V., Spanidis, Y., El Bisari, S., & Troupis, T. (2021). Erectile dysfunction treatment using stem cells: a review. Medicines, 8(1), 2. https://doi.org/https://doi.org/10.3390/medicines8010002
Rezaee, M. E., Ward, C. E., Brandes, E. R., Munarriz, R. M., & Gross, M. S. (2020). A review of economic evaluations of erectile dysfunction therapies. Sexual Medicine Reviews, 8(3), 497-503. https://doi.org/https://doi.org/10.1016/j.sxmr.2019.06.001
Ryu, J. K., Kim, D. H., Song, K. M., Ryu, D. S., Kim, S. N., Shin, D. H., Yi, T., Suh, J. K., & Song, S. (2016). Intracavernous delivery of clonal mesenchymal stem cells rescues erectile function in the streptozotocin‐induced diabetic mouse. Andrology, 4(1), 172-184. https://doi.org/https://doi.org/10.1111/andr.12138
Ryu, J. K., Kim, D. H., Song, K. M., Yi, T., Suh, J. K., & Song, S. U. (2014). Intracavernous delivery of clonal mesenchymal stem cells restores erectile function in a mouse model of cavernous nerve injury. The Journal of Sexual Medicine, 11(2), 411-423. https://doi.org/https://doi.org/10.1111/jsm.12380
Shamloul, R., & Ghanem, H. (2013). Erectile dysfunction. The Lancet, 381(9861), 153-165. https://doi.org/https://doi.org/10.1016/S0140-6736(12)60520-0
Singh, J. C., Devasia, A., Gnanaraj, L., & Chacko, K. N. (2005). Erectile dysfunction. National Medical Journal of India, 18(3), 139.
Sultana, A., Grice, P., Vukina, J., Pearce, I., & Modgil, V. (2022). Indications and characteristics of penile traction and vacuum erection devices. Nature Reviews Urology, 19(2), 84-100. https://doi.org/https://doi.org/10.1038/s41585-021-00532-7
Sun, C., Lin, H., Yu, W., Li, X., Chen, Y., Qiu, X., Wang, R., & Dai, Y. (2012). Neurotrophic effect of bone marrow mesenchymal stem cells for erectile dysfunction in diabetic rats. International journal of andrology, 35(4), 601-607. https://doi.org/https://doi.org/10.1111/j.1365-2605.2012.01250.x
Testa, B., & Kraemer, S. (2007). The biochemistry of drug metabolism–An introduction-Testa-2007-chemistry & biodiversity-wiley online library. Chem. Biodivers, 4(3).
Tzoumas, N., Farrah, T. E., Dhaun, N., & Webb, D. J. (2020). Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease. British Journal of Pharmacology, 177(24), 5467-5488. https://doi.org/https://doi.org/10.1111/bph.14920
Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature reviews immunology, 8(9), 726-736. https://doi.org/https://doi.org/10.1038/nri2395
van Waterschoot, R. A., & Schinkel, A. H. (2011). A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice. Pharmacological reviews, 63(2), 390-410. https://doi.org/https://doi.org/10.1124/pr.110.002584
Wolf, C. R., Smith, G., & Smith, R. L. (2000). Science, medicine, and the future-Pharmacogenetics. British Medical Journal, 320(7240), 987-990.
Wrishko, R., Sorsaburu, S., Wong, D., Strawbridge, A., & McGill, J. (2009). Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. The journal of sexual medicine, 6(7), 2039-2048. https://doi.org/https://doi.org/10.1111/j.1743-6109.2009.01301.x
You, D., Jang, M. J., Lee, J., Jeong, I. G., Kim, H. S., Moon, K. H., Suh, N., & Kim, C.-S. (2013). Periprostatic implantation of human bone marrow-derived mesenchymal stem cells potentiates recovery of erectile function by intracavernosal injection in a rat model of cavernous nerve injury. Urology, 81(1), 104-110. https://doi.org/https://doi.org/10.1016/j.urology.2012.08.046
You, D., Jang, M. J., Lee, J., Suh, N., Jeong, I. G., Sohn, D. W., Kim, S. W., Ahn, T. Y., & Kim, C. S. (2013). Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue‐derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. The Prostate, 73(3), 278-286. https://doi.org/https://doi.org/10.1002/pros.22567
Zanger, U. M., & Schwab, M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & therapeutics, 138(1), 103-141. https://doi.org/https://doi.org/10.1016/j.pharmthera.2012.12.007
Albersen, M., Fandel, T. M., Lin, G., Wang, G., Banie, L., Lin, C.-S., & Lue, T. F. (2010). Injections of adipose tissue-derived stem cells and stem cell lysate improve recovery of erectile function in a rat model of cavernous nerve injury. The journal of sexual medicine, 7(10), 3331-3340. https://doi.org/https://doi.org/10.1111/j.1743-6109.2010.01875.x
Aytaç, Mckinlay, & Krane. (1999). The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU international, 84(1), 50-56. https://doi.org/https://doi.org/10.1046/j.1464-410x.1999.00142.x
Beaudreau, S. A., Van Moorleghem, K., Dodd, S. M., Liou-Johnson, V., Suresh, M., & Gould, C. E. (2021). Satisfaction with a vacuum constriction device for erectile dysfunction among middle-aged and older veterans. Clinical Gerontologist, 44(3), 307-315. https://doi.org/https://doi.org/10.1080/07317115.2020.1823922
Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the Rule of 5 and drugability. Advanced drug delivery reviews, 101, 89-98. https://doi.org/https://doi.org/10.1016/j.addr.2016.05.007
Bilal, A., & Abbasi, N. U. H. (2020). Cognitive behavioral sex therapy: An emerging treatment option for nonorganic erectile dysfunction in young men: A feasibility pilot study. Sexual medicine, 8(3), 396-407. https://doi.org/https://doi.org/10.1016/j.esxm.2020.05.005
Boulton, A., Selam, J.-L., Sweeney, M., & Ziegler, D. (2001). Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia, 44, 1296-1301. https://doi.org/https://doi.org/10.1007/s001250100656
Casiraghi, F., Remuzzi, G., Abbate, M., & Perico, N. (2013). Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem cell reviews and reports, 9(1), 65-79. https://doi.org/https://doi.org/10.1007/s12015-011-9345-4
Ciocanel, O., Power, K., & Eriksen, A. (2019). Interventions to treat erectile dysfunction and premature ejaculation: an overview of systematic reviews. Sexual medicine, 7(3), 251-269. https://doi.org/https://doi.org/10.1016/j.esxm.2019.06.001
Cosconati, S., Forli, S., Perryman, A. L., Harris, R., Goodsell, D. S., & Olson, A. J. (2010). Virtual screening with AutoDock: theory and practice. Expert opinion on drug discovery, 5(6), 597-607. https://doi.org/https://doi.org/10.1517/17460441.2010.484460
Christensen, B. S., Grønbæk, M., Osler, M., Pedersen, B. V., Graugaard, C., & Frisch, M. (2011). Associations between physical and mental health problems and sexual dysfunctions in sexually active Danes. The journal of sexual medicine, 8(7), 1890-1902. https://doi.org/https://doi.org/10.1111/j.1743-6109.2010.02145.x
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1), 42717. https://doi.org/https://doi.org/10.1038/srep42717
Di, L. (2014). The role of drug metabolizing enzymes in clearance. Expert opinion on drug metabolism & toxicology, 10(3), 379-393. https://doi.org/https://doi.org/10.1517/17425255.2014.876006
Elena, B. W., Zachary, M., Haritha, P., Graham, B. A., & Wayne, H. J. (2023). Current status of intracavernosal injection therapy in erectile dysfunction. Expert Opinion on Pharmacotherapy, 24(8), 925-933. https://doi.org/https://doi.org/10.1080/14656566.2023.2204189
Ferguson III, J. E., & Carson III, C. C. (2013). Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons. Arab Journal of Urology, 11(3), 222-229. https://doi.org/https://doi.org/10.1016/j.aju.2013.07.009
Francis, S. H., & Corbin, J. D. (2005). Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction. Expert opinion on drug metabolism & toxicology, 1(2), 283-293. https://doi.org/https://doi.org/10.1517/17425255.1.2.283
Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006). Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nature reviews Drug discovery, 5(8), 689-702. https://doi.org/https://doi.org/10.1038/nrd2030
Gu, S. j., Li, M., Yuan, Y. m., Xin, Z. c., & Guan, R. l. (2021). A novel flavonoid derivative of icariside II improves erectile dysfunction in a rat model of cavernous nerve injury. Andrology, 9(6), 1893-1901. https://doi.org/https://doi.org/10.1111/andr.13065
Giuliano, F., Denys, P., & Joussain, C. (2023). Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data. Toxins, 15(6), 382. https://doi.org/https://doi.org/10.3390/toxins15060382
Hatzimouratidis, K., & Hatzichristou, D. G. (2004). Treatment options for erectile dysfunction in patients failing oral drug therapy. EAU Update Series, 2(2), 75-83. https://doi.org/https://doi.org/10.1016/j.euus.2004.03.001
Hatzimouratidis, K., & Hatzichristou, D. G. (2005). A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs, 65, 1621-1650. https://doi.org/https://doi.org/10.2165/00003495-200565120-00003
Hatzimouratidis, K., Salonia, A., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., McCullough, A., Torres, L. O., & Khera, M. (2016). Pharmacotherapy for erectile dysfunction: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). The journal of sexual medicine, 13(4), 465-488. https://doi.org/https://doi.org/10.1016/j.jsxm.2016.01.016
Hollenberg, P. F. (2002). Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug metabolism reviews, 34(1-2), 17-35. https://doi.org/https://doi.org/10.1081/DMR-120001387
Huang, S. M., Strong, J. M., Zhang, L., Reynolds, K. S., Nallani, S., Temple, R., Abraham, S., Habet, S. A., Baweja, R. K., & Burckart, G. J. (2008). New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. The Journal of clinical pharmacology, 48(6), 662-670. https://doi.org/https://doi.org/10.1177/0091270007312153
Jarow, J. P., Nana-Sinkam, P., Sabbagh, M., & Eskew, A. (1996). Outcome analysis of goal directed therapy for impotence. The Journal of urology, 155(5), 1609-1612. https://doi.org/https://doi.org/10.1016/S0022-5347(01)66142-1
Jones, P., Sandoval Barba, H., Johnson, M. I., Soomro, N., Robson, W., Ferguson, J., & Aning, J. J. (2021). Erectile dysfunction after robotic radical prostatectomy: real-life impact of vacuum erection device clinic. Journal of Clinical Urology, 14(5), 325-331. https://doi.org/https://doi.org/10.1177/205141582094663
Kalsi, J., & Kell, P. (2004). Update on oral treatments for male erectile dysfunction. Journal of the European Academy of Dermatology and Venereology, 18(3), 267-274. https://doi.org/https://doi.org/10.1111/j.1468-3083.2004.00885.x
Karakus, S., & Burnett, A. L. (2020). The medical and surgical treatment of erectile dysfunction: a review and update. Can J Urol, 27(S3), 28-35.
Kirchmair, J., Göller, A. H., Lang, D., Kunze, J., Testa, B., Wilson, I. D., Glen, R. C., & Schneider, G. (2015). Predicting drug metabolism: experiment and/or computation? Nature reviews Drug discovery, 14(6), 387-404. https://doi.org/https://doi.org/10.1038/nrd4581
Khayyamfar, F., Foroutan, S. K., Farhadi, E., & Ghasemlouei, A. (2021). The impact of vacuum constrictive device on the treatment of erectile dysfunction in spinal cord injured patients. Translational Research in Urology, 3(4), 170-175. https://doi.org/https://doi.org/10.22034/TRU.2021.314753.1087
Langarizadeh, M. A., Salary, A., Tavakoli, M. R., Nejad, B. G., Fadaei, S., Jahani, Z., & Forootanfar, H. (2023). An overview of the history, current strategies, and potential future treatment approaches in erectile dysfunction: a comprehensive review. Sexual Medicine Reviews, qead014. https://doi.org/https://doi.org/10.1093/sxmrev/qead014
Lewis, R. (2004). Definition, classification, and epidemiology of sexual dysfunction. Sexual dysfunction, 3-37.
Lin, G., Banie, L., Ning, H., Bella, A. J., Lin, C. S., & Lue, T. F. (2009). Potential of adipose‐derived stem cells for treatment of erectile dysfunction. The journal of sexual medicine, 6(Supplement_3), 320-327. https://doi.org/https://doi.org/10.1111/j.1743-6109.2008.01190.x
Lin, G., Yang, R., Banie, L., Wang, G., Ning, H., Li, L. C., Lue, T. F., & Lin, C. S. (2010). Effects of transplantation of adipose tissue‐derived stem cells on prostate tumor. The Prostate, 70(10), 1066-1073. https://doi.org/https://doi.org/10.1002/pros.21140
Lue, T. F., Giuliano, F., Montorsi, F., Rosen, R. C., Andersson, K. E., Althof, S., Christ, G., Hatzichristou, D., Hirsch, M., & Kimoto, Y. (2004). Summary of the recommendations on sexual dysfunctions in men. The journal of sexual medicine, 1(1), 6-23. https://doi.org/https://doi.org/10.1111/j.1743-6109.2004.10104.x
Mangner, N., Linke, A., Oberbach, A., Kullnick, Y., Gielen, S., Sandri, M., Hoellriegel, R., Matsumoto, Y., Schuler, G., & Adams, V. (2013). Exercise training prevents TNF-α induced loss of force in the diaphragm of mice. PLoS One, 8(1), e52274. https://doi.org/https://doi.org/10.1371/journal.pone.0052274
McCabe, M. P., Sharlip, I. D., Lewis, R., Atalla, E., Balon, R., Fisher, A. D., Laumann, E., Lee, S. W., & Segraves, R. T. (2016). Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. The journal of sexual medicine, 13(2), 144-152. https://doi.org/https://doi.org/10.1016/j.jsxm.2015.12.034
Mukherjee, A., Su, A., & Rajan, K. (2021). Deep learning model for identifying critical structural motifs in potential endocrine disruptors. Journal of chemical information and modeling, 61(5), 2187-2197. https://doi.org/https://doi.org/10.1021/acs.jcim.0c01409
O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of cheminformatics, 3(1), 1-14. https://doi.org/https://doi.org/10.1186/1758-2946-3-33
Padma-Nathan, H., & Giuliano, F. (2001). Oral drug therapy for erectile dysfunction. Urologic Clinics of North America, 28(2), 321-334. https://doi.org/https://doi.org/10.1016/S0094-0143(05)70141-5
Peng, Z., Yang, L., Dong, Q., Wei, Q., Liu, L., & Yang, B. (2017). Efficacy and safety of tadalafil once-a-day versus tadalafil on-demand in patients with erectile dysfunction: a systematic review and meta-analyses. Urologia Internationalis, 99(3), 343-352. https://doi.org/https://doi.org/10.1159/000477496
Porst, H., Burnett, A., Brock, G., Ghanem, H., Giuliano, F., Glina, S., Hellstrom, W., Martin-Morales, A., Salonia, A., & Sharlip, I. (2013). SOP conservative (medical and mechanical) treatment of erectile dysfunction. The journal of sexual medicine, 10(1), 130-171. https://doi.org/https://doi.org/10.1111/jsm.12023
Prockop, D. (2007). “Stemness” does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clinical Pharmacology & Therapeutics, 82(3), 241-243. https://doi.org/https://doi.org/10.1038/sj.clpt.6100313
Protogerou, V., Chrysikos, D., Karampelias, V., Spanidis, Y., El Bisari, S., & Troupis, T. (2021). Erectile dysfunction treatment using stem cells: a review. Medicines, 8(1), 2. https://doi.org/https://doi.org/10.3390/medicines8010002
Rezaee, M. E., Ward, C. E., Brandes, E. R., Munarriz, R. M., & Gross, M. S. (2020). A review of economic evaluations of erectile dysfunction therapies. Sexual Medicine Reviews, 8(3), 497-503. https://doi.org/https://doi.org/10.1016/j.sxmr.2019.06.001
Ryu, J. K., Kim, D. H., Song, K. M., Ryu, D. S., Kim, S. N., Shin, D. H., Yi, T., Suh, J. K., & Song, S. (2016). Intracavernous delivery of clonal mesenchymal stem cells rescues erectile function in the streptozotocin‐induced diabetic mouse. Andrology, 4(1), 172-184. https://doi.org/https://doi.org/10.1111/andr.12138
Ryu, J. K., Kim, D. H., Song, K. M., Yi, T., Suh, J. K., & Song, S. U. (2014). Intracavernous delivery of clonal mesenchymal stem cells restores erectile function in a mouse model of cavernous nerve injury. The Journal of Sexual Medicine, 11(2), 411-423. https://doi.org/https://doi.org/10.1111/jsm.12380
Shamloul, R., & Ghanem, H. (2013). Erectile dysfunction. The Lancet, 381(9861), 153-165. https://doi.org/https://doi.org/10.1016/S0140-6736(12)60520-0
Singh, J. C., Devasia, A., Gnanaraj, L., & Chacko, K. N. (2005). Erectile dysfunction. National Medical Journal of India, 18(3), 139.
Sultana, A., Grice, P., Vukina, J., Pearce, I., & Modgil, V. (2022). Indications and characteristics of penile traction and vacuum erection devices. Nature Reviews Urology, 19(2), 84-100. https://doi.org/https://doi.org/10.1038/s41585-021-00532-7
Sun, C., Lin, H., Yu, W., Li, X., Chen, Y., Qiu, X., Wang, R., & Dai, Y. (2012). Neurotrophic effect of bone marrow mesenchymal stem cells for erectile dysfunction in diabetic rats. International journal of andrology, 35(4), 601-607. https://doi.org/https://doi.org/10.1111/j.1365-2605.2012.01250.x
Testa, B., & Kraemer, S. (2007). The biochemistry of drug metabolism–An introduction-Testa-2007-chemistry & biodiversity-wiley online library. Chem. Biodivers, 4(3).
Tzoumas, N., Farrah, T. E., Dhaun, N., & Webb, D. J. (2020). Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease. British Journal of Pharmacology, 177(24), 5467-5488. https://doi.org/https://doi.org/10.1111/bph.14920
Uccelli, A., Moretta, L., & Pistoia, V. (2008). Mesenchymal stem cells in health and disease. Nature reviews immunology, 8(9), 726-736. https://doi.org/https://doi.org/10.1038/nri2395
van Waterschoot, R. A., & Schinkel, A. H. (2011). A critical analysis of the interplay between cytochrome P450 3A and P-glycoprotein: recent insights from knockout and transgenic mice. Pharmacological reviews, 63(2), 390-410. https://doi.org/https://doi.org/10.1124/pr.110.002584
Wolf, C. R., Smith, G., & Smith, R. L. (2000). Science, medicine, and the future-Pharmacogenetics. British Medical Journal, 320(7240), 987-990.
Wrishko, R., Sorsaburu, S., Wong, D., Strawbridge, A., & McGill, J. (2009). Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil. The journal of sexual medicine, 6(7), 2039-2048. https://doi.org/https://doi.org/10.1111/j.1743-6109.2009.01301.x
You, D., Jang, M. J., Lee, J., Jeong, I. G., Kim, H. S., Moon, K. H., Suh, N., & Kim, C.-S. (2013). Periprostatic implantation of human bone marrow-derived mesenchymal stem cells potentiates recovery of erectile function by intracavernosal injection in a rat model of cavernous nerve injury. Urology, 81(1), 104-110. https://doi.org/https://doi.org/10.1016/j.urology.2012.08.046
You, D., Jang, M. J., Lee, J., Suh, N., Jeong, I. G., Sohn, D. W., Kim, S. W., Ahn, T. Y., & Kim, C. S. (2013). Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue‐derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. The Prostate, 73(3), 278-286. https://doi.org/https://doi.org/10.1002/pros.22567
Zanger, U. M., & Schwab, M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & therapeutics, 138(1), 103-141. https://doi.org/https://doi.org/10.1016/j.pharmthera.2012.12.007